Given the strong link between ovarian fibrosis and systemic metabolic dysfunction in PCOS, future studies should incorporate evaluations of glucose homeostasis, lipid metabolism, and insulin signaling to more comprehensively assess the therapeutic potential of PFD in addressing both reproductive and metabolic features of the syndrome. Here, INS is linked to polycystic ovary syndrome.